Flea and Tick Medication Recalls 2026: What's Actually Been Pulled
🚨 The short answer, up front: As of this writing, no major branded flea and tick medication has actually been recalled or pulled from the US market in 2026. What has happened is different, and arguably more important to understand: an ongoing FDA safety warning for the isoxazoline drug class, and an EPA review of spot-on topical products that has not (yet) resulted in any product being removed. If you've seen a headline claiming otherwise, keep reading — we checked the primary sources so you don't have to guess.
Search "flea and tick recall 2026" and you'll find a mix of outdated warnings recycled as breaking news, alarmist social posts, and the occasional real pet food recall wrongly lumped in with flea and tick products. We went straight to the FDA, the EPA, and the AVMA's own recall tracker to separate what's actually happened from what's only been flagged, petitioned, or is still under review. Here's the real, current picture — plus exactly how to check for yourself going forward, since this is a fast-moving situation.
In this article
- The current status: no 2026 recall, but real scrutiny
- Recall vs. warning vs. "under review": know the difference
- The isoxazoline warning: what it actually covers
- The Seresto collar controversy: still unresolved
- The EPA's spot-on product review
- What a real recall has looked like before
- How to check for real recalls yourself
- What to do if your pet had a bad reaction
- Frequently asked questions
The current status: no 2026 recall, but real scrutiny
Let's be precise, because the wording matters a great deal here. According to reporting on the EPA's ongoing evaluation, the agency has said it is not banning or pulling any topical or spot-on flea and tick products off the market, at least not yet — despite tens of thousands of adverse event reports involving skin burns, seizures, and deaths tied to certain manufacturers' products. That single sentence is the most accurate summary of where things stand: intense scrutiny, no removal.
This matters because "recalled," "flagged," "under investigation," and "linked to adverse events" get used interchangeably in a lot of pet-owner content, and they are not the same thing. If your dog or cat is currently on a flea and tick product prescribed or recommended by your veterinarian, that product being mentioned in the news cycle does not automatically mean it has been recalled or is unsafe to continue using without first talking to your vet.
Recall vs. warning vs. "under review": know the difference
| Status | What it means | Is the product still for sale? |
|---|---|---|
| Recall | Manufacturer voluntarily withdraws the product, or a regulator orders its removal, usually tied to a specific lot, defect, or contamination | No — recalled units should not be sold or used |
| Safety communication / warning | FDA or EPA flags a known risk, often updates the label with new warning language, and asks vets and owners to be aware | Yes — remains legally available and FDA-approved or EPA-registered |
| Under review / being evaluated | A regulator is actively collecting and analyzing adverse event data but has not yet taken formal action | Yes — no change in legal status during the review |
| Congressional pressure / advocacy call for recall | Lawmakers or advocacy groups publicly urge a recall, which is a request, not a regulatory action | Yes — the manufacturer and regulator can decline to act on the request |
Nearly everything currently circulating about flea and tick products in 2026 falls into the second and third categories: warnings and ongoing reviews. That's still worth knowing about — but it's a different, less urgent situation than an actual recall.
The isoxazoline warning: what it actually covers
The FDA maintains an active animal drug safety communication alerting pet owners and veterinarians to the potential for neurologic adverse events in dogs and cats treated with drugs in the isoxazoline class. This class includes:
- Bravecto (fluralaner)
- Credelio (lotilaner)
- NexGard (afoxolaner)
- Simparica (sarolaner)
- Revolution Plus (selamectin and sarolaner)
The reported adverse events include muscle tremors, ataxia (loss of coordination), and seizures. Importantly, all five of these products remain FDA-approved and on the market — the communication resulted in updated warning language on product labels, not a withdrawal. If your pet has a history of seizures or neurologic issues, this is exactly the kind of thing to flag with your vet before starting or continuing an isoxazoline product, but it is not, on its own, a reason to panic or stop a prescribed treatment without medical guidance.
This isoxazoline warning is sometimes recycled in "2026 recall" content as if it were new breaking news. The underlying FDA communication has been public and periodically updated for several years and continues to apply in 2026 — it is ongoing awareness guidance, not a fresh 2026 recall event. If an article presents this warning as a brand-new recall, that's a sign the content hasn't been checked against the primary FDA source.
The Seresto collar controversy: still unresolved
Separately, the Seresto flea and tick collar, made by Elanco Animal Health, has faced sustained scrutiny after a congressional subcommittee report linked the collar to tens of thousands of incident reports and thousands of pet deaths, and called on Elanco to institute a voluntary recall. Elanco has consistently defended the product's safety profile and has not recalled it. As of this writing, Seresto collars remain legally available for purchase, and no regulator has ordered a recall — this remains a case of sustained public pressure and advocacy without a corresponding formal regulatory action.
The EPA's spot-on product review
The EPA has been conducting an extended evaluation of topical, spot-on flea and tick products in response to a large volume of incident reports. This review is explicitly described as ongoing, with the agency considering possible future actions that could include formula changes or, potentially, market removal — but no such action had been finalized as of this writing. If you use a topical spot-on product and want the most current status, the EPA's own pet product page is the place to check, since this is precisely the kind of situation that can change with little advance notice.
What a real recall has looked like before
To recognize the real thing when it happens, it helps to know what an actual flea and tick product recall looked like historically. In the early 2000s, the EPA reached agreements with Hartz Mountain Corporation requiring the company to cease sale and distribution of, and conduct a product recovery for, specific cat and kitten flea and tick drop products following reports of adverse reactions including tremors, hair loss, and deaths. That involved specific product names, specific EPA registration numbers, and an actual withdrawal from shelves — the clear hallmarks of a genuine recall, as opposed to a warning or an ongoing review.
How to check for real recalls yourself
- FDA Center for Veterinary Medicine — maintains official animal drug recalls and safety communications, including any future action on isoxazoline products.
- EPA pesticide product and label system — the right place to check for EPA-regulated topical spot-on products, searchable by EPA registration number or brand name.
- American Veterinary Medical Association recall and alerts page — aggregates verified recalls across pet product categories, updated as new recalls are announced.
- Check the product label for an EPA registration number first, so you know which agency (FDA or EPA) actually regulates your specific product before searching.
Because this is a fast-moving area, treat any list — including this one — as a snapshot, and verify directly against these primary sources before making a decision about your pet's current medication.
What to do if your pet had a bad reaction
- Contact your veterinarian promptly if you notice tremors, unsteady movement, seizures, unusual skin irritation, or other concerning symptoms after applying or administering a flea and tick product.
- Do not stop a prescribed treatment on your own without medical guidance — untreated flea and tick exposure carries its own real risks, including disease transmission.
- Report the adverse event to the FDA (for FDA-regulated animal drugs) or the EPA (for EPA-registered pesticide products) — these reports are part of what drives future safety reviews and, when warranted, recalls.
- Keep the product packaging and lot number until the situation is resolved, in case it becomes relevant to a future recall or your vet's evaluation.
For more on specific products mentioned in this article, see our related coverage:
Frequently asked questions
Is it safe to keep using Bravecto, NexGard, or Simparica right now?
Why do so many articles claim there's a "2026 flea and tick recall" if there isn't one?
Will this article be updated if an actual recall happens?
Is a "voluntary recall" less serious than one ordered by regulators?
- FDA — Animal Drug Safety Communication on isoxazoline class flea and tick products
- FDA — Safe Use of Flea and Tick Products in Pets, Center for Veterinary Medicine
- EPA — Protecting Pets from Fleas and Ticks, ongoing spot-on product evaluation reporting
- EPA — historical enforcement record, Hartz Mountain Corporation flea and tick drop recovery
- American Veterinary Medical Association — Recalls/Safety Alerts Search
- U.S. House Committee on Oversight and Reform, Subcommittee on Economic and Consumer Policy — Seresto collar report
